BBTV

About Us

latest videos

An Interview with Steve Burrill

  1. Adapting to Change, an Interview with Steve Burrill
  2. No Real Healthcare Reform, Only Insurance Reform
  3. Financing Biotech in 2010
  4. From Personalized Medicine to Preemptive Medicine
  5. Stem Cells and Other Promising New Technologies
  6. FAST Word Association Game, with Steve Burrill

MYGN – Myriad Genetics CEO Peter Meldrum Interviewed by Charles Duncan

  1. A Brief History of Myriad Genetics
  2. BRAC Analysis, Myriad Genetics’ Primary Revenue Driver
  3. Is a European Expansion to be Expected from Myriad Genetics? Checklist and Roadmap
  4. Optimal Chemotherapy Dosing with OnDose, from Myriad Genetics
  5. Myriad Genetics’ Latest Diagnostic (PROLARIS) Predicts Prostate Cancer Recurrence.
  6. Patenting Genes: What if the ACLU Wins the Case Against Myriad Genetics?
  7. Financials: How is Myriad Genetics Planning to Return Cash to Investors?

Paion AG CEO Wolfgang Soehngen Interviewed by Swati Kumar

  1. Batman is Back, Busting Clots with Desmotoplase
  2. Paion De-Risks Pipeline with Acquisition of New Value Driver CNS 7056
  3. IPaion’s Search & Develop Strategy: Get the Proof of Concept Faster and Cheaper than Pharma

Addex CEO Vincent Mutel Interviewed by Ram Selvaraju

  1. Dim That Receptor Activity with Addex’s Allosteric Modulation
  2. Addex’s New Lead Molecule ADX48621, Expected To Be Partnered Soon?
  3. December 2009, A Major Setback for Addex. Use of Cash, and Other Pipeline Molecules
  4. ADDEX Undervalued? What Could Drive Stock Price In The Next 6 Months

Osteoporosis Breakthrough, Professor Gerard Karsenty

  1. Major Breakthrough in $5bn Osteoporosis Market
  2. Inhibiting Serotonin Synthesis in the Gut, Rationale for Treating Osteoporosis
  3. How Does an Anabolic Treatment Compare to Other Approaches in Development for Osteoporosis?
  4. Study of Rare Genetic Disease Leads to New Target for the Treatment of Most Common Bone Disease
<< Previous123456789Next >>

  • Categories

    • Shows
      • Biotech in the Money
      • Wall Street on BBTV
      • Science Breakthrough
      • The Jan Buck Show
      • 60sec Pitches
      • Special Interview
      • Report on Location
      • Wall Street
    • Series
      • The Stem Cell Review
      • Alzheimer's Today
      • The MedTech Report
      • Stem Cell Review
    • Channels
      • Science
      • Finance
      • Business
    • About
      • about sub
      • about sub 2

  • Acknowlegments

    nasdaq nasdaq

  • Editor’s Pick

    The Stem Cell Review Series is an awesome series on stem cells.. isn’t that awesome?!

  • Popular Shows

    • Marina’s Buy Side
    • Marina’s Sell Side
    • Marina Undecided
    • Bill Takes Over the World
    • Jan Buck Takes Over Bill
  • Channels
    • Science
  • Series
    • The Stem Cell Review
  • Shows
    • Biotech in the Money
    • Report on Location
    • Science Breakthrough
    • Special Interview
    • The Jan Buck Show
    • Wall Street
    • Wall Street 2
    • Wall Street on BBTV
  • About
    • about sub
    • about sub 2